NEW YORK (GenomeWeb News) – Molecular diagnostics company Exosome Diagnostics has raised $5 million, it disclosed in a document filed with the US Securities and Exchange Commission last week.

The New York-based firm declined to comment, but in its amended Form D filed with the SEC it said that in total it is targeting $6 million in the offering. The type of securities offered is a mixture of debt; options, warrants or other rights to acquire another security; and security to be acquired upon exercise of an option, warrant, or other right to acquire security.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Two researchers have found that behavioral genetic defenses in criminal cases don't tend to affect outcomes, according to Popular Science.

Researchers report that while host genetics influence the oral microbiome, they don't appear to affect cavity-causing microbes, the Economist says.

Pandas' gut microbiomes change as what they eat changes with the seasons, writes Discover's Inkfish blog.

In PLOS this week: comparative genomic study of malaria-linked macaque parasite, search for apple root reference genes, and more.